Cystic Fibrosis News Today Daily Digest

Cystic Fibrosis Weekly Update Contents: Healthy Volunteers Do Well in AR-501 Trial for Chronic Lung Infections Cystic Fibrosis and Herpes Are Not the Same Thing Renovion Raises $8.1M to Advance Lung Inflammation, Mucus Treatment Healthy Volunteers Do Well in AR-501 Trial for Chronic Lung Infections Jun 24, 2020 07:00 am | Ines Martins, PhD AR-501, an inhaled treatment candidate for chronic lung infections in people with cystic fibrosis (CF), has been deemed safe and well-tolerated in healthy volunteers, results from the first part of a Phase 1/2a clinical trial show. The trial’s safety monitoring committee (SMC) and a data safety monitoring board (DSMB) have recommended that all doses tested […] The post Healthy Volunteers Do Well in AR-501 Trial for Chronic Lung Infections appeared first on Cystic Fibrosis News Today. Read More Cystic Fibrosis and Herpes Are Not the Same Thing Jun 23, 2020 03:00 pm | Bailey Vincent I don’t have herpes. I need to clarify this. I don’t have herpes, or Hep C, or cancer, even though many seem to think I do. Although I empathize with the Herps and Hep sufferers of the world, I am going to lose my mind if another person comments on health-related posts to suggest magician-doctor-cults […] The post Cystic Fibrosis and Herpes Are Not the Same Thing appeared first on Cystic Fibrosis News Today. Read More Renovion Raises $8.1M to Advance Lung Inflammation, Mucus Treatment Jun 23, 2020 07:00 am | Vanessa Pataia Renovion has raised $8.1 million in a financing round, supporting further development and planned clinical testing of ARINA-1, a nebulized treatment for chronic lung diseases like cystic fibrosis (CF) and non-CF bronchiectasis, and for lung transplants. “Patient and laboratory studies have shown that ARINA-1 significantly improves mucus clearance while reducing inflammation. There are limited options available and […] The post Renovion Raises $8.1M to Advance Lung Inflammation, Mucus Treatment appeared first on Cystic Fibrosis News Today. Read More   Recent News Alexion Charitable Foundation Giving $1.1M to Assist Rare Disease Community During Pandemic Eloxx Resumes Enrollment in Phase 2 Trial of ELX-02 in Europe, Israel 4DMT Receives Up to $14M from CFF for Development of Customized Gene Carrier Poll Results Highlight Lack of Awareness About Cystic Fibrosis in the UK Second-hand Smoke Affects Metabolism in Infants and Children with CF, Study Finds